Abstract:Anti-programmed cell death 1 protein monoclonal antibodies are a novel and exciting treatment for several malignancies. Their mechanism of action involve blocking the protective programmed cell death protein-1 receptor, thereby allowing for lymphocytes to identify and destroy cancer cells. Although effective, side effects and complications can ensue. We present a case of Horner's syndrome, myositis, and myasthenia gravis (MG) in a patient treated with pembrolizumab. Case Presentation: A 59 year-old-female with… Show more
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.